How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "8812"
  ["article_id"]=>
  string(4) "8812"
  [1]=>
  string(100) "Genentech Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)"
  ["article_title"]=>
  string(100) "Genentech Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)"
  [2]=>
  string(150) "South San Francisco, CA -- April 7, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food an"
  ["short_description"]=>
  string(150) "South San Francisco, CA -- April 7, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food an"
  [3]=>
  string(249) "South San Francisco, CA -- April 7, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its..."
  ["description"]=>
  string(249) "South San Francisco, CA -- April 7, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(271) "https://www.drugs.com/clinical_trials/genentech-provides-regulatory-update-risdiplam-spinal-muscular-atrophy-sma-18524.html?utm_source=ddc&utm_medium=rss&utm_campaign=Genentech+Provides+Regulatory+Update+on+Risdiplam+for+the+Treatment+of+Spinal+Muscular+Atrophy+%28SMA%29"
  ["blog_url"]=>
  string(271) "https://www.drugs.com/clinical_trials/genentech-provides-regulatory-update-risdiplam-spinal-muscular-atrophy-sma-18524.html?utm_source=ddc&utm_medium=rss&utm_campaign=Genentech+Provides+Regulatory+Update+on+Risdiplam+for+the+Treatment+of+Spinal+Muscular+Atrophy+%28SMA%29"
  [15]=>
  string(19) "2020-04-07 11:04:33"
  ["add_date"]=>
  string(19) "2020-04-07 11:04:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Genentech Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atr

South San Francisco, CA -- April 7, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announc

array(40) {
  [0]=>
  string(4) "8913"
  ["article_id"]=>
  string(4) "8913"
  [1]=>
  string(114) "Unproven COVID-19 health claims: China’s crackdown on ads for oral sprays, probiotics and anti-hangover tea"
  ["article_title"]=>
  string(114) "Unproven COVID-19 health claims: China’s crackdown on ads for oral sprays, probiotics and anti-hangover tea"
  [2]=>
  string(129) "The Chinese authorities have named and shamed a string of fake advertisement, mostly surrounding unproven COVID-19 health claims."
  ["short_description"]=>
  string(129) "The Chinese authorities have named and shamed a string of fake advertisement, mostly surrounding unproven COVID-19 health claims."
  [3]=>
  string(129) "The Chinese authorities have named and shamed a string of fake advertisement, mostly surrounding unproven COVID-19 health claims."
  ["description"]=>
  string(129) "The Chinese authorities have named and shamed a string of fake advertisement, mostly surrounding unproven COVID-19 health claims."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(214) "https://www.nutraingredients-asia.com/Article/2020/04/07/Unproven-COVID-19-health-claims-China-s-crackdown-on-ads-for-oral-sprays-probiotics-and-anti-hangover-tea?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(214) "https://www.nutraingredients-asia.com/Article/2020/04/07/Unproven-COVID-19-health-claims-China-s-crackdown-on-ads-for-oral-sprays-probiotics-and-anti-hangover-tea?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-07 09:22:00"
  ["add_date"]=>
  string(19) "2020-04-07 09:22:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:12"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Unproven COVID-19 health claims: China’s crackdown on ads for oral sprays, probioti

The Chinese authorities have named and shamed a string of fake advertisement, mostly surrounding unproven COVID-19 healt

array(40) {
  [0]=>
  string(4) "8793"
  ["article_id"]=>
  string(4) "8793"
  [1]=>
  string(246) "Alnylam Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration and Submits Marketing Authorization Application to the European Medicines Agency for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1"
  ["article_title"]=>
  string(246) "Alnylam Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration and Submits Marketing Authorization Application to the European Medicines Agency for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1"
  [2]=>
  string(150) "CAMBRIDGE, Mass.--(BUSINESS WIRE)-- April 07, 2020 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today annou"
  ["short_description"]=>
  string(150) "CAMBRIDGE, Mass.--(BUSINESS WIRE)-- April 07, 2020 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today annou"
  [3]=>
  string(251) "CAMBRIDGE, Mass.--(BUSINESS WIRE)-- April 07, 2020 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and..."
  ["description"]=>
  string(251) "CAMBRIDGE, Mass.--(BUSINESS WIRE)-- April 07, 2020 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(300) "https://www.drugs.com/nda/lumasiran_200407.html?utm_source=ddc&utm_medium=rss&utm_campaign=Alnylam+Completes+Rolling+Submission+of+New+Drug+Application+to+the+U.S.+Food+and+Drug+Administration+and+Submits+Marketing+Authorization+Application+to+the+European+Medicines+Agency+for+Lumasiran+for+the+Trea"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/nda/lumasiran_200407.html?utm_source=ddc&utm_medium=rss&utm_campaign=Alnylam+Completes+Rolling+Submission+of+New+Drug+Application+to+the+U.S.+Food+and+Drug+Administration+and+Submits+Marketing+Authorization+Application+to+the+European+Medicines+Agency+for+Lumasiran+for+the+Trea"
  [15]=>
  string(19) "2020-04-07 09:04:55"
  ["add_date"]=>
  string(19) "2020-04-07 09:04:55"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:39"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Alnylam Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Adm

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- April 07, 2020 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi the

array(40) {
  [0]=>
  string(4) "8813"
  ["article_id"]=>
  string(4) "8813"
  [1]=>
  string(119) "FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Potential Treatment for COVID-19"
  ["article_title"]=>
  string(119) "FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Potential Treatment for COVID-19"
  [2]=>
  string(150) "ATLANTA and MIAMI, April 6, 2020 /PRNewswire/ -- Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Inno"
  ["short_description"]=>
  string(150) "ATLANTA and MIAMI, April 6, 2020 /PRNewswire/ -- Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Inno"
  [3]=>
  string(245) "ATLANTA and MIAMI, April 6, 2020 /PRNewswire/ -- Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned..."
  ["description"]=>
  string(245) "ATLANTA and MIAMI, April 6, 2020 /PRNewswire/ -- Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/fda-clears-way-ridgeback-biotherapeutics-begin-human-testing-promising-potential-covid-19-18525.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Clears+the+Way+for+Ridgeback+Biotherapeutics+to+begin+Human+Testing+of+a+Promising+Potential+Treatment+for+COVID-1"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/fda-clears-way-ridgeback-biotherapeutics-begin-human-testing-promising-potential-covid-19-18525.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Clears+the+Way+for+Ridgeback+Biotherapeutics+to+begin+Human+Testing+of+a+Promising+Potential+Treatment+for+COVID-1"
  [15]=>
  string(19) "2020-04-07 07:04:57"
  ["add_date"]=>
  string(19) "2020-04-07 07:04:57"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA Clears the Way for Ridgeback Biotherapeutics to begin Human Testing of a Promising Pot

ATLANTA and MIAMI, April 6, 2020 /PRNewswire/ -- Ridgeback Biotherapeutics LP, a closely held biotec

array(40) {
  [0]=>
  string(4) "8759"
  ["article_id"]=>
  string(4) "8759"
  [1]=>
  string(37) "UK PM Boris Johnson in intensive care"
  ["article_title"]=>
  string(37) "UK PM Boris Johnson in intensive care"
  [2]=>
  string(87) "The prime minister remains conscious and not on a ventilator at this time, official say"
  ["short_description"]=>
  string(87) "The prime minister remains conscious and not on a ventilator at this time, official say"
  [3]=>
  string(87) "The prime minister remains conscious and not on a ventilator at this time, official say"
  ["description"]=>
  string(87) "The prime minister remains conscious and not on a ventilator at this time, official say"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(91) "http://www.pharmatimes.com/news/breaking_news_uk_pm_boris_johnson_in_intensive_care_1337843"
  ["blog_url"]=>
  string(91) "http://www.pharmatimes.com/news/breaking_news_uk_pm_boris_johnson_in_intensive_care_1337843"
  [15]=>
  string(19) "2020-04-07 04:14:41"
  ["add_date"]=>
  string(19) "2020-04-07 04:14:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:37"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

UK PM Boris Johnson in intensive care

The prime minister remains conscious and not on a ventilator at this time, official say

array(40) {
  [0]=>
  string(4) "8800"
  ["article_id"]=>
  string(4) "8800"
  [1]=>
  string(103) "Pharmacy staff should wear masks if they cannot keep two metres away from colleagues, new guidance says"
  ["article_title"]=>
  string(103) "Pharmacy staff should wear masks if they cannot keep two metres away from colleagues, new guidance says"
  [2]=>
  string(157) "New guidance for pharmacists working during the COVID-19 pandemic says they should always wear fluid-resistant surgical masks if they can’t distanc"
  ["short_description"]=>
  string(157) "New guidance for pharmacists working during the COVID-19 pandemic says they should always wear fluid-resistant surgical masks if they can’t distanc"
  [3]=>
  string(217) "New guidance for pharmacists working during the COVID-19 pandemic says they should always wear fluid-resistant surgical masks if they can’t distance themselves by two metres from anyone else in the pharmacy."
  ["description"]=>
  string(217) "New guidance for pharmacists working during the COVID-19 pandemic says they should always wear fluid-resistant surgical masks if they can’t distance themselves by two metres from anyone else in the pharmacy."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(181) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacy-staff-should-wear-masks-if-they-cannot-keep-two-metres-away-from-colleagues-new-guidance-says/20207878.article"
  ["blog_url"]=>
  string(181) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacy-staff-should-wear-masks-if-they-cannot-keep-two-metres-away-from-colleagues-new-guidance-says/20207878.article"
  [15]=>
  string(19) "2020-04-07 00:30:00"
  ["add_date"]=>
  string(19) "2020-04-07 00:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Pharmacy staff should wear masks if they cannot keep two metres away from colleagues, new

New guidance for pharmacists working during the COVID-19 pandemic says they should always wear fluid-resistant surgic

array(40) {
  [0]=>
  string(4) "8972"
  ["article_id"]=>
  string(4) "8972"
  [1]=>
  string(62) "BioData free video conferencing enables COVID-19 collaboration"
  ["article_title"]=>
  string(62) "BioData free video conferencing enables COVID-19 collaboration"
  [2]=>
  string(150) "The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic."
  ["short_description"]=>
  string(150) "The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic."
  [3]=>
  string(150) "The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic."
  ["description"]=>
  string(150) "The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(155) "https://www.outsourcing-pharma.com/Article/2020/04/06/BioData-video-tool-enables-COVID-19-collaboration?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(155) "https://www.outsourcing-pharma.com/Article/2020/04/06/BioData-video-tool-enables-COVID-19-collaboration?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-06 23:19:00"
  ["add_date"]=>
  string(19) "2020-04-06 23:19:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

BioData free video conferencing enables COVID-19 collaboration

The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at 

array(40) {
  [0]=>
  string(4) "8809"
  ["article_id"]=>
  string(4) "8809"
  [1]=>
  string(68) "Five ways to promote self-care for you and your team during COVID-19"
  ["article_title"]=>
  string(68) "Five ways to promote self-care for you and your team during COVID-19"
  [2]=>
  string(138) "It is more important than ever to ensure the wellbeing of the frontline pharmacy workforce; here are some tips on how this can be done."
  ["short_description"]=>
  string(138) "It is more important than ever to ensure the wellbeing of the frontline pharmacy workforce; here are some tips on how this can be done."
  [3]=>
  string(138) "It is more important than ever to ensure the wellbeing of the frontline pharmacy workforce; here are some tips on how this can be done."
  ["description"]=>
  string(138) "It is more important than ever to ensure the wellbeing of the frontline pharmacy workforce; here are some tips on how this can be done."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(173) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/five-ways-to-promote-self-care-for-you-and-your-team-during-covid-19/20207874.article"
  ["blog_url"]=>
  string(173) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/five-ways-to-promote-self-care-for-you-and-your-team-during-covid-19/20207874.article"
  [15]=>
  string(19) "2020-04-06 22:18:00"
  ["add_date"]=>
  string(19) "2020-04-06 22:18:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:43"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:43"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Five ways to promote self-care for you and your team during COVID-19

It is more important than ever to ensure the wellbeing of the frontline pharmacy workforce; here are some tips on how

array(40) {
  [0]=>
  string(4) "8950"
  ["article_id"]=>
  string(4) "8950"
  [1]=>
  string(83) "Study results could improve antimicrobial surfaces for medical implants and devices"
  ["article_title"]=>
  string(83) "Study results could improve antimicrobial surfaces for medical implants and devices"
  [2]=>
  string(93) "A study by the University of Bristol has identified new ways nanopillars can damage bacteria."
  ["short_description"]=>
  string(93) "A study by the University of Bristol has identified new ways nanopillars can damage bacteria."
  [3]=>
  string(93) "A study by the University of Bristol has identified new ways nanopillars can damage bacteria."
  ["description"]=>
  string(93) "A study by the University of Bristol has identified new ways nanopillars can damage bacteria."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/study-results-suggest-new-ways-nanopillars-can-damage-bacter/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/study-results-suggest-new-ways-nanopillars-can-damage-bacter/"
  [15]=>
  string(19) "2020-04-06 22:14:26"
  ["add_date"]=>
  string(19) "2020-04-06 22:14:26"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Study results could improve antimicrobial surfaces for medical implants and devices

A study by the University of Bristol has identified new ways nanopillars can damage bacteria.

array(40) {
  [0]=>
  string(4) "8973"
  ["article_id"]=>
  string(4) "8973"
  [1]=>
  string(42) "Saama launches COVID-19 data collaboration"
  ["article_title"]=>
  string(42) "Saama launches COVID-19 data collaboration"
  [2]=>
  string(148) "The companyâs EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus."
  ["short_description"]=>
  string(148) "The companyâs EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus."
  [3]=>
  string(148) "The companyâs EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus."
  ["description"]=>
  string(148) "The companyâs EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(161) "https://www.outsourcing-pharma.com/Article/2020/04/06/Saama-Technologies-launches-COVID-19-data-collaboration?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(161) "https://www.outsourcing-pharma.com/Article/2020/04/06/Saama-Technologies-launches-COVID-19-data-collaboration?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-06 22:10:00"
  ["add_date"]=>
  string(19) "2020-04-06 22:10:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Saama launches COVID-19 data collaboration

The companyâs EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate developm

array(40) {
  [0]=>
  string(4) "8976"
  ["article_id"]=>
  string(4) "8976"
  [1]=>
  string(50) "Science 37 guide offers COVID-19 advice for trials"
  ["article_title"]=>
  string(50) "Science 37 guide offers COVID-19 advice for trials"
  [2]=>
  string(147) "The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption."
  ["short_description"]=>
  string(147) "The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption."
  [3]=>
  string(147) "The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption."
  ["description"]=>
  string(147) "The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(154) "https://www.outsourcing-pharma.com/Article/2020/04/06/Whitepaper-offers-COVID-19-clinical-trial-advice?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(154) "https://www.outsourcing-pharma.com/Article/2020/04/06/Whitepaper-offers-COVID-19-clinical-trial-advice?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-06 21:25:00"
  ["add_date"]=>
  string(19) "2020-04-06 21:25:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Science 37 guide offers COVID-19 advice for trials

The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety

array(40) {
  [0]=>
  string(4) "9004"
  ["article_id"]=>
  string(4) "9004"
  [1]=>
  string(37) "New Process Welds Clear Plastic Parts"
  ["article_title"]=>
  string(37) "New Process Welds Clear Plastic Parts"
  [2]=>
  string(153) "&#nl        Laser welding of plastic parts creates precise, high-quality, particulate-free joints for medical devices, consumer products and other assemb"
  ["short_description"]=>
  string(153) "&#nl        Laser welding of plastic parts creates precise, high-quality, particulate-free joints for medical devices, consumer products and other assemb"
  [3]=>
  string(368) "&#nl        
Laser welding of plastic parts creates precise, high-quality, particulate-free joints for medical devices, consumer products and other assemblies. However, for the process to work, the laser light must pass through the top part to be absorbed by the bottom part. Welding a clear plastic part to another clear plastic part was not possible.
&#nl      "
  ["description"]=>
  string(368) "&#nl        
Laser welding of plastic parts creates precise, high-quality, particulate-free joints for medical devices, consumer products and other assemblies. However, for the process to work, the laser light must pass through the top part to be absorbed by the bottom part. Welding a clear plastic part to another clear plastic part was not possible.
&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(80) "https://www.assemblymag.com/articles/95614-new-process-welds-clear-plastic-parts"
  ["blog_url"]=>
  string(80) "https://www.assemblymag.com/articles/95614-new-process-welds-clear-plastic-parts"
  [15]=>
  string(19) "2020-04-06 21:00:00"
  ["add_date"]=>
  string(19) "2020-04-06 21:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:50"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

New Process Welds Clear Plastic Parts

&#nl

Laser welding of plastic parts creates precise, high-quality, particulate-free joints for medical devices